UK DHSC · June 10, 2026

Proposed 2026 changes to the statutory scheme for branded medicines pricing

Consultation on amendments to the headline payment percentage and consultation procedure of the branded medicines pricing control scheme.

Medium obligation Framework Pharmaceuticals Market Access & Reimbursement UK PharmaceuticalsPricing

Proposed changes to the headline payment percentage and consultation procedure of the statutory scheme to control the cost of branded health service medicines.

Read the official source ↗

Published by UK DHSC. HealthSignal links to the original document; the summary above is extracted from the source text.